Global Spinal Muscular Atrophy Market Size, Status and Forecast 2018-2025

Number Of Pages: 96
Publisher Name: QYRESEARCH
Published date: 10/22/2018

In 2017, the global Spinal Muscular Atrophy market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.

This report focuses on the global Spinal Muscular Atrophy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Spinal Muscular Atrophy development in United States, Europe and China.

The key players covered in this study
Lonis Pharmaceuticals
F. Hoffmann-La Roche
AveXis
Novartis
Cytokinetics
Ionis Pharmaceuticals
...

Market segment by Type, the product can be split into
Early Stage Candidates
Late Stage Candidates

Market segment by Application, split into
Hospital
Clinic
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Spinal Muscular Atrophy status, future forecast, growth opportunity, key market and key players.
To present the Spinal Muscular Atrophy development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Spinal Muscular Atrophy are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Spinal Muscular Atrophy Market Size Growth Rate by Type (2013-2025)
1.4.2 Early Stage Candidates
1.4.3 Late Stage Candidates
1.5 Market by Application
1.5.1 Global Spinal Muscular Atrophy Market Share by Application (2013-2025)
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Spinal Muscular Atrophy Market Size
2.2 Spinal Muscular Atrophy Growth Trends by Regions
2.2.1 Spinal Muscular Atrophy Market Size by Regions (2013-2025)
2.2.2 Spinal Muscular Atrophy Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Spinal Muscular Atrophy Market Size by Manufacturers
3.1.1 Global Spinal Muscular Atrophy Revenue by Manufacturers (2013-2018)
3.1.2 Global Spinal Muscular Atrophy Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Spinal Muscular Atrophy Market Concentration Ratio (CR5 and HHI)
3.2 Spinal Muscular Atrophy Key Players Head office and Area Served
3.3 Key Players Spinal Muscular Atrophy Product/Solution/Service
3.4 Date of Enter into Spinal Muscular Atrophy Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Spinal Muscular Atrophy Market Size by Type (2013-2018)
4.2 Global Spinal Muscular Atrophy Market Size by Application (2013-2018)

5 United States
5.1 United States Spinal Muscular Atrophy Market Size (2013-2018)
5.2 Spinal Muscular Atrophy Key Players in United States
5.3 United States Spinal Muscular Atrophy Market Size by Type
5.4 United States Spinal Muscular Atrophy Market Size by Application

6 Europe
6.1 Europe Spinal Muscular Atrophy Market Size (2013-2018)
6.2 Spinal Muscular Atrophy Key Players in Europe
6.3 Europe Spinal Muscular Atrophy Market Size by Type
6.4 Europe Spinal Muscular Atrophy Market Size by Application

7 China
7.1 China Spinal Muscular Atrophy Market Size (2013-2018)
7.2 Spinal Muscular Atrophy Key Players in China
7.3 China Spinal Muscular Atrophy Market Size by Type
7.4 China Spinal Muscular Atrophy Market Size by Application

8 Japan
8.1 Japan Spinal Muscular Atrophy Market Size (2013-2018)
8.2 Spinal Muscular Atrophy Key Players in Japan
8.3 Japan Spinal Muscular Atrophy Market Size by Type
8.4 Japan Spinal Muscular Atrophy Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Spinal Muscular Atrophy Market Size (2013-2018)
9.2 Spinal Muscular Atrophy Key Players in Southeast Asia
9.3 Southeast Asia Spinal Muscular Atrophy Market Size by Type
9.4 Southeast Asia Spinal Muscular Atrophy Market Size by Application

10 India
10.1 India Spinal Muscular Atrophy Market Size (2013-2018)
10.2 Spinal Muscular Atrophy Key Players in India
10.3 India Spinal Muscular Atrophy Market Size by Type
10.4 India Spinal Muscular Atrophy Market Size by Application

11 Central & South America
11.1 Central & South America Spinal Muscular Atrophy Market Size (2013-2018)
11.2 Spinal Muscular Atrophy Key Players in Central & South America
11.3 Central & South America Spinal Muscular Atrophy Market Size by Type
11.4 Central & South America Spinal Muscular Atrophy Market Size by Application

12 International Players Profiles
12.1 Lonis Pharmaceuticals
12.1.1 Lonis Pharmaceuticals Company Details
12.1.2 Company Description and Business Overview
12.1.3 Spinal Muscular Atrophy Introduction
12.1.4 Lonis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2013-2018)
12.1.5 Lonis Pharmaceuticals Recent Development
12.2 F. Hoffmann-La Roche
12.2.1 F. Hoffmann-La Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Spinal Muscular Atrophy Introduction
12.2.4 F. Hoffmann-La Roche Revenue in Spinal Muscular Atrophy Business (2013-2018)
12.2.5 F. Hoffmann-La Roche Recent Development
12.3 AveXis
12.3.1 AveXis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Spinal Muscular Atrophy Introduction
12.3.4 AveXis Revenue in Spinal Muscular Atrophy Business (2013-2018)
12.3.5 AveXis Recent Development
12.4 Novartis
12.4.1 Novartis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Spinal Muscular Atrophy Introduction
12.4.4 Novartis Revenue in Spinal Muscular Atrophy Business (2013-2018)
12.4.5 Novartis Recent Development
12.5 Cytokinetics
12.5.1 Cytokinetics Company Details
12.5.2 Company Description and Business Overview
12.5.3 Spinal Muscular Atrophy Introduction
12.5.4 Cytokinetics Revenue in Spinal Muscular Atrophy Business (2013-2018)
12.5.5 Cytokinetics Recent Development
12.6 Ionis Pharmaceuticals
12.6.1 Ionis Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Spinal Muscular Atrophy Introduction
12.6.4 Ionis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2013-2018)
12.6.5 Ionis Pharmaceuticals Recent Development

13 Market Forecast 2018-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2018-2025)
13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Spinal Muscular Atrophy Key Market Segments
Table Key Players Spinal Muscular Atrophy Covered
Table Global Spinal Muscular Atrophy Market Size Growth Rate by Type 2013-2025 (Million US$)
Figure Global Spinal Muscular Atrophy Market Size Market Share by Type 2013-2025
Figure Early Stage Candidates Figures
Table Key Players of Early Stage Candidates
Figure Late Stage Candidates Figures
Table Key Players of Late Stage Candidates
Table Global Spinal Muscular Atrophy Market Size Growth by Application 2013-2025 (Million US$)
Figure Hospital Case Studies
Figure Clinic Case Studies
Figure Others Case Studies
Figure Spinal Muscular Atrophy Report Years Considered
Table Global Spinal Muscular Atrophy Market Size 2013-2025 (Million US$)
Figure Global Spinal Muscular Atrophy Market Size and Growth Rate 2013-2025 (Million US$)
Table Global Spinal Muscular Atrophy Market Size by Regions 2013-2025 (Million US$)
Table Global Spinal Muscular Atrophy Market Size by Regions 2013-2018 (Million US$)
Table Global Spinal Muscular Atrophy Market Share by Regions 2013-2018
Figure Global Spinal Muscular Atrophy Market Share by Regions 2013-2018
Figure Global Spinal Muscular Atrophy Market Share by Regions 2018
Table Market Top Trends
Table Global Spinal Muscular Atrophy Revenue by Manufacturers (2013-2018) (Million US$)
Table Global Spinal Muscular Atrophy Market Share by Manufacturers (2013-2018)
Figure Global Spinal Muscular Atrophy Market Share by Manufacturers in 2018
Table Global Spinal Muscular Atrophy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Spinal Muscular Atrophy Product/Solution/Service
Table Date of Enter into Spinal Muscular Atrophy Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$)
Table Global Spinal Muscular Atrophy Market Size Share by Type (2013-2018)
Figure Global Spinal Muscular Atrophy Market Size Market Share by Type (2013-2018)
Table Global Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$)
Table Global Spinal Muscular Atrophy Market Size Share by Application (2013-2018)
Figure Global Spinal Muscular Atrophy Market Size Market Share by Application (2013-2018)
Figure Global Spinal Muscular Atrophy Revenue Market Share by Application in 2017
Figure United States Spinal Muscular Atrophy Market Size 2013-2018 (Million US$)
Table United States Key Players Spinal Muscular Atrophy Revenue (2017-2018) (Million US$)
Table United States Key Players Spinal Muscular Atrophy Market Share (2017-2018)
Table United States Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$)
Table United States Spinal Muscular Atrophy Market Share by Type (2013-2018)
Table United States Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$)
Table United States Spinal Muscular Atrophy Market Share by Application (2013-2018)
Figure Europe Spinal Muscular Atrophy Market Size 2013-2018 (Million US$)
Table Europe Key Players Spinal Muscular Atrophy Revenue (2017-2018) (Million US$)
Table Europe Key Players Spinal Muscular Atrophy Market Share (2017-2018)
Table Europe Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$)
Table Europe Spinal Muscular Atrophy Market Share by Type (2013-2018)
Table Europe Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$)
Table Europe Spinal Muscular Atrophy Market Share by Application (2013-2018)
Figure China Spinal Muscular Atrophy Market Size 2013-2018 (Million US$)
Table China Key Players Spinal Muscular Atrophy Revenue (2017-2018) (Million US$)
Table China Key Players Spinal Muscular Atrophy Market Share (2017-2018)
Table China Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$)
Table China Spinal Muscular Atrophy Market Share by Type (2013-2018)
Table China Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$)
Table China Spinal Muscular Atrophy Market Share by Application (2013-2018)
Figure Japan Spinal Muscular Atrophy Market Size 2013-2018 (Million US$)
Table Japan Key Players Spinal Muscular Atrophy Revenue (2017-2018) (Million US$)
Table Japan Key Players Spinal Muscular Atrophy Market Share (2017-2018)
Table Japan Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$)
Table Japan Spinal Muscular Atrophy Market Share by Type (2013-2018)
Table Japan Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$)
Table Japan Spinal Muscular Atrophy Market Share by Application (2013-2018)
Figure Southeast Asia Spinal Muscular Atrophy Market Size 2013-2018 (Million US$)
Table Southeast Asia Key Players Spinal Muscular Atrophy Revenue (2017-2018) (Million US$)
Table Southeast Asia Key Players Spinal Muscular Atrophy Market Share (2017-2018)
Table Southeast Asia Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$)
Table Southeast Asia Spinal Muscular Atrophy Market Share by Type (2013-2018)
Table Southeast Asia Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$)
Table Southeast Asia Spinal Muscular Atrophy Market Share by Application (2013-2018)
Figure India Spinal Muscular Atrophy Market Size 2013-2018 (Million US$)
Table India Key Players Spinal Muscular Atrophy Revenue (2017-2018) (Million US$)
Table India Key Players Spinal Muscular Atrophy Market Share (2017-2018)
Table India Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$)
Table India Spinal Muscular Atrophy Market Share by Type (2013-2018)
Table India Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$)
Table India Spinal Muscular Atrophy Market Share by Application (2013-2018)
Figure Central & South America Spinal Muscular Atrophy Market Size 2013-2018 (Million US$)
Table Central & South America Key Players Spinal Muscular Atrophy Revenue (2017-2018) (Million US$)
Table Central & South America Key Players Spinal Muscular Atrophy Market Share (2017-2018)
Table Central & South America Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$)
Table Central & South America Spinal Muscular Atrophy Market Share by Type (2013-2018)
Table Central & South America Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$)
Table Central & South America Spinal Muscular Atrophy Market Share by Application (2013-2018)
Table Lonis Pharmaceuticals Company Details
Table Lonis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2013-2018) (Million US$)
Figure Lonis Pharmaceuticals Revenue Growth Rate in Spinal Muscular Atrophy Business (2013-2018)
Table Lonis Pharmaceuticals Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Revenue in Spinal Muscular Atrophy Business (2013-2018)(Million US$)
Figure F. Hoffmann-La Roche Revenue Growth Rate in Spinal Muscular Atrophy Business (2013-2018)
Table F. Hoffmann-La Roche Recent Development
Table AveXis Company Details
Table AveXis Revenue in Spinal Muscular Atrophy Business (2013-2018)(Million US$)
Figure AveXis Revenue Growth Rate in Spinal Muscular Atrophy Business (2013-2018)
Table AveXis Recent Development
Table Novartis Company Details
Table Novartis Revenue in Spinal Muscular Atrophy Business (2013-2018)(Million US$)
Figure Novartis Revenue Growth Rate in Spinal Muscular Atrophy Business (2013-2018)
Table Novartis Recent Development
Table Cytokinetics Company Details
Table Cytokinetics Revenue in Spinal Muscular Atrophy Business (2013-2018)(Million US$)
Figure Cytokinetics Revenue Growth Rate in Spinal Muscular Atrophy Business (2013-2018)
Table Cytokinetics Recent Development
Table Ionis Pharmaceuticals Company Details
Table Ionis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2013-2018)(Million US$)
Figure Ionis Pharmaceuticals Revenue Growth Rate in Spinal Muscular Atrophy Business (2013-2018)
Table Ionis Pharmaceuticals Recent Development
Table Global Spinal Muscular Atrophy Market Size by Regions (Million US$) 2018-2025
Figure Global Spinal Muscular Atrophy Market Size Share by Regions (2018-2025)
Figure Global Spinal Muscular Atrophy Market Size Share by Regions in 2025
Figure United States Spinal Muscular Atrophy Market Size Forecast (2018-2025)(Million USD)
Figure Europe Spinal Muscular Atrophy Market Size Forecast (2018-2025)(Million USD)
Figure China Spinal Muscular Atrophy Market Size Forecast (2018-2025)(Million USD)
Figure Japan Spinal Muscular Atrophy Market Size Forecast (2018-2025)(Million USD)
Figure Southeast Asia Spinal Muscular Atrophy Market Size Forecast (2018-2025)(Million USD)
Figure India Spinal Muscular Atrophy Market Size Forecast (2018-2025)(Million USD)
Figure Central & South America Spinal Muscular Atrophy Market Size Forecast (2018-2025)(Million USD)
Table Global Spinal Muscular Atrophy Market Size by Product (2018-2025) (Million US$)
Figure Global Spinal Muscular Atrophy Market Size by Product (2018-2025)
Figure Global Spinal Muscular Atrophy Market Size by Product in 2025
Table Global Spinal Muscular Atrophy Market Size by Application (2018-2025) (Million US$)
Figure Global Spinal Muscular Atrophy Market Size by Application (2018-2025)
Figure Global Spinal Muscular Atrophy Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


null

Electronic files(PDF) of market research reports will be dispatched within 12 to 24 hours. (Mon-Fri IST)

Select License Type

Need Help?
SUBSCRIBE TO THE MAILING TO KEEP UP WITH LATEST NEWS AND UPDATES
x
We use cookies to deliver the best possible experience on our website by improving the user experience, personalizing your visit, and compiling aggregate statistics. By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more visit our Privacy policy page.